TRU-SCD

Published by: Jude Jonassaint

Description

TRU-SCD is an application specifically designed to help patients with sickle cell disease track their pain level over time while also recording passively biometric information made available from an AppleWatch or other health band saving biometric information accessible with user permission through the Apple HealthKit framework.TRU-SCD could be prescribed by a hematologist to help monitor a patient's progress with a new or existing therapy.
Hide Show More...

Screenshots

TRU-SCD FAQ

  • Is TRU-SCD free?

    Yes, TRU-SCD is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is TRU-SCD legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does TRU-SCD cost?

    TRU-SCD is free.

  • What is TRU-SCD revenue?

    To get estimated revenue of TRU-SCD app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Finland yet.
Ratings History

TRU-SCD Reviews

No Reviews in Finland
App doesn't have any reviews in Finland yet.

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet

TRU-SCD Installs

Last 30 days

TRU-SCD Revenue

Last 30 days

TRU-SCD Revenue and Downloads

Gain valuable insights into TRU-SCD performance with our analytics.
Sign up now to access downloads, revenue, and more.

App Info

Publisher
Jude Jonassaint
Languages
English
Recent release
0.5 (3 years ago )
Released on
Apr 17, 2021 (3 years ago )
Last Updated
4 days ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.